The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
Moiola L, Barcella V, Benatti S, Capobianco M, Capra R, Cinque P, Comi G, Fasolo MM, Franzetti F, Galli M, Gerevini S, Meroni L, Origoni M, Prosperini L, Puoti M, Scarpazza C, Tortorella C, Zaffaroni M, Riva A.
Moiola L, et al. Among authors: scarpazza c.
Mult Scler. 2021 Mar;27(3):331-346. doi: 10.1177/1352458520952311. Epub 2020 Sep 17.
Mult Scler. 2021.
PMID: 32940121